1. Home
  2. ATYR vs TG Comparison

ATYR vs TG Comparison

Compare ATYR & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.81

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.14

Market Cap

301.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
TG
Founded
2005
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
301.0M
IPO Year
2015
1989

Fundamental Metrics

Financial Performance
Metric
ATYR
TG
Price
$0.81
$7.14
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.1M
166.4K
Earning Date
11-06-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,000.00
$691,173,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$109.53
Revenue Growth
N/A
43.30
52 Week Low
$0.64
$6.25
52 Week High
$7.29
$9.43

Technical Indicators

Market Signals
Indicator
ATYR
TG
Relative Strength Index (RSI) 55.62 36.36
Support Level $0.70 $7.31
Resistance Level $0.75 $7.61
Average True Range (ATR) 0.05 0.22
MACD 0.01 -0.04
Stochastic Oscillator 76.89 7.55

Price Performance

Historical Comparison
ATYR
TG

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: